SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-038675
Filing Date
2018-09-18
Accepted
2018-09-18 17:08:59
Documents
77
Period of Report
2018-09-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002406x2_8k.htm 8-K 21651
2 EXHIBIT 23.1 s002406x2_ex23-1.htm EX-23.1 3920
3 EXHIBIT 99.1 s002406x2_ex99-1.htm EX-99.1 200954
4 EXHIBIT 99.2 s002406x2_ex99-2.htm EX-99.2 866476
  Complete submission text file 0001140361-18-038675.txt   7559148

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT akca-20180918.xml EX-101.INS 1538794
6 XBRL TAXONOMY EXTENSION SCHEMA akca-20180918.xsd EX-101.SCH 60209
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20180918_cal.xml EX-101.CAL 79567
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20180918_def.xml EX-101.DEF 393380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20180918_lab.xml EX-101.LAB 956894
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20180918_pre.xml EX-101.PRE 566657
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 181076331
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1